title: The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms.
authors: Eleftheria
authors: E
authors: Hatzimichael
authors: Aggeliki
authors: A
authors: Dasoula
authors: Leonidas
authors: L
authors: Benetatos
authors: Alexandros
authors: A
authors: Makis
authors: Justin
authors: J
authors: Stebbing
authors: Tim
authors: T
authors: Crook
authors: Maria
authors: M
authors: Syrrou
authors: Konstantinos L
authors: KL
authors: Bourantas
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D050761:Cyclin-Dependent Kinase Inhibitor p57 / Q000235:genetics*; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000235:genetics; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000235:genetics; D054219:Neoplasms, Plasma Cell / Q000235:genetics*
chemical_list: C493964:CDKN1C protein, human; D050761:Cyclin-Dependent Kinase Inhibitor p57; D004273:DNA, Neoplasm